The World s Top 10 Biotechnology Companies (JNJ, ) #global #healthcare #companies

Posted On May 19 2017 by

#biotechnology companies # The World s Top 10 Biotechnology Companies (JNJ, ROG.VX) In 1919, Hungarian agricultural engineer Karl Ereky coined the term “biotechnology ” to describe the merging of biology and technology. Ereky’s vision has been realized by thousands of companies and research institutions that are developing a growing list of biotechnology products. While the big money in biotech is in pharmaceuticals, medical devices and diagnostics, many advances are also being made to develop more-resilient crops, biofuels, biomaterials and pollution controls. In general, any medicine made with or derived from living organisms is considered a biotech therapy, or biologic. The …

Kira forte st john – s wort 40 dragees Lichtwer Pharma #exl #pharma

Posted On May 19 2017 by

#lichtwer pharma # Kira forte st john s wort 40 dragees Lichtwer Pharma Text will follow On May 25, is a European law published on health claims. This law determines which claims about health benefits are granted if you touting specific products in the category of dietary or nutritional supplements, such as on the packaging, on a website or in brochures.It is limited in promoting the sale of specific products by banning health claims not by the EFSA (European Food and Safety Authority ) are approved. It preserves the freedom of expression and may make statements on generic active ingredients. …

Seamus Mulligan s Azur to merge with US pharma firm in $500m deal – Rockwell College Union #pharma #engineering

Posted On May 19 2017 by

#azur pharma # Seamus Mulligan’s Azur to merge with US pharma firm in $500m deal Sunday, 16th October 2011 IRISH PHARMA group Azur, which is led by former Elan executive Séamus Mulligan (1977), has agreed to merge with Nasdaq-listed Jazz Pharmaceuticals in a deal that values the Dublin-based company at $500 million (365.5 million). Seamus was the 2005 Union Business Lunch guest speaker. This is an all-share transaction that will give Azurs shareholders just over 20 per cent of the combined entity. Jazzs owners will hold the balance. The deal, which was announced in California on Monday, is subject to …

German pharma company hiring 300 in Des Plaines – Manufacturing News – Crain s Chicago Business #pharma #stocks

Posted On May 18 2017 by

#pharmaceutical companies in chicago # Weather Market Search German pharma company plans to hire 300 in Des Plaines A German pharmaceutical company plans to hire hundreds of people to staff a massive new production facility in Des Plaines. Vetter wants to purchase and demolish a former Salvation Army office campus at Algonquin and Mount Prospect roads in the north suburb, according to Des Plaines Ald. Mike Charewicz. In its place, Vetter will construct a $320 million, 1.2 million-square-foot property, Charewicz confirmed. At least 300 people will work at the facility, but the company could eventually hire more. Vetter will create …

China – s Drug-Price Cuts Are Hitting Big Pharma Where It Hurts #spectrum #pharma

Posted On May 17 2017 by

#chinese pharmaceutical companies # China’s Drug-Price Cuts Are Hitting Big Pharma Where It Hurts The world’s largest pharmaceutical companies are facing a roadblock in China as a state-led campaign to slash drug prices has triggered a slowdown in sales growth. One of the biggest problems: China’s government-run health insurance funds, which are struggling to keep up with an ageing population and surging incidence of diseases like cancer or diabetes. As they grapple with tighter budgets and a slowing economy, many of these funds are capping reimbursements to patients and pushing local authorities to negotiate with companies to lower drug prices. …

Boston – s biotech, pharma success will breed more success – The Boston Globe #horizon #pharma

Posted On May 17 2017 by

#pharmaceutical companies in boston # Based on what you ve read recently, you might be interested in theses stories In Pa. boomers see the American Dream slipping away Boundaries to hope Flooding of coast, caused by global warming, has already begun Nick Cafardo: How does Boston compare with Toronto, Baltimore entering final stretch? 99 cents a week for the first 4 weeks Subscribe Subscribe Save 50% off the regular rate Boston’s biotech, pharma success will breed more success By Christoph Westphal July 14, 2014 Boston has benefited from an unexpected positive development in the last decade. Where we used to …

Here s Why Raptor Pharmaceuticals Corp #industry #pharmacy

Posted On May 16 2017 by

#raptor pharma # Here s Why Raptor Pharmaceuticals Corp. Plunged Today Sep 14, 2015 at 11:39AM What. Raptor Pharmaceuticals (NASDAQ:RPTP ). a small-cap biopharma company specializing in the development of treatments for rare diseases, saw its stock plunge by nearly 40% today on heavy volume. This massive downward move was precipitated by the announcement that the company’s experimental drug for nonalcoholic steatohepatitis (NASH) in children, RP103, failed to meet its primary endpoint in a second mid-stage trial. Because RP103 reportedly failed to make any meaningful impact on liver fibrosis, Raptor expects to discontinue the drug’s clinical program for NASH following …

It – s Like Viagra for Pharma Ads: Pfizer – s $1 #alembic #pharma

Posted On May 16 2017 by

#pharma marketing news # It’s Like Viagra for Pharma Ads: Pfizer’s $1.4 Billion Marketing Blitz Pfizer Inc.’s tab to keep its best-selling drugs on top and turn its newer ones into tomorrow’s blockbusters? More than $1 billion. America’s biggest drugmaker led the pharmaceutical industry in advertising in 2014, boosting spending even as other corporate giants such as Procter Gamble Co. Toyota Motor Corp. and L’Oreal SA cut back, according to data from Kantar Media. Drug industry spending on consumer ads grew to $4.54 billion last year, 21 percent more than in 2013, according to research firm Nielsen NV. New York-based …

The world – s largest pharmaceutical market access conference #offshore #pharma

Posted On May 16 2017 by

#world pharma # OVER 250 ATTENDEES 16 COUNTRIES REPRESENTED Great networking, very useful to hear from a mix of pharma companies and payers about market access and evidence requirements – Novartis Pharma About Pharma Pricing & Market Access Congress “Excellent presenters, their knowledge and enthusiasm meant attendees were well educated” Senior Director, European Physician & Payer Forum Get involved PHARMA PRICING & MARKET ACCESS PAST SPONSORS Your sponsorship opportunity SAMPLE OF WHO ATTENDS “Interesting speakers- useful updates on key topics, some thought provoking perspectives-Director, A Connect PAST KEYNOTE SPEAKERS

S K PHARMA MACHINERY PRIVATE LIMITED – Company, directors and contact details #top #generic #drug #companies

Posted On May 15 2017 by

#sk pharma # S K PHARMA MACHINERY PRIVATE LIMITED *Industry classification is derived from National Industrial Classification. If the company has changed line of business without intimating the Registrar or is a diversified business, classification may be different. We make no warranties about accuracy of industrial classification. Update Information We are adding and updating information about hundreds of thousands of companies every day, and periodically add companies to the queue for being updated. You can ask for a company to be added to the front of the queue for updating, especially useful if the address, directors, or other critical information …